Topical Anti-inflammatory Agents for Seborrheic Dermatitis of the Face or Scalp Summary of a Cochrane Review

被引：13

作者：

Kastarinen, Helena ^{[1
]}

Okokon, Enembe O. ^{[2
]}

Verbeek, Jos H. ^{[3
]}

机构：

[1] Reg Off Eastern Finland, Social Insurance Inst Finland, Kuopio, Finland

[2] Univ Calabar, Teaching Hosp, Dept Community Med, Calabar, Nigeria

[3] Finnish Inst Occupat Hlth, Cochrane Occupat Safety & Hlth Review Grp, Kuopio, Finland

来源：

JAMA DERMATOLOGY | 2015年 / 151卷 / 02期

关键词：

D O I：

10.1001/jamadermatol.2014.3186

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

CLINICAL QUESTION Are there differences in effectiveness between topical anti-inflammatory treatments ( steroids, calcineurin inhibitors, or lithium salts) and placebo or azoles in the treatment of seborrheic dermatitis of the face and scalp in adults? BOTTOM LINE The topical anti-inflammatory treatments were more effective in achieving total clearance of symptoms than placebo by 1.4-fold to 8.5-fold, but there are no considerable differences in the anti-inflammatory topical treatments or in comparison with azoles for short-term treatment. There is no evidence of treatment effects in long-term, continuous, or intermittent use of these compounds despite the chronic nature of the disease.

引用

页码：221 / 222

页数：2